First oral blood thinner for treatment of children with venous thromboembolism |
Editorial
eMediNexus Coverage from: 
First oral blood thinner for treatment of children with venous thromboembolism

3 Read Comments                

Dabigatran has been accorded US FDA approval as the first oral blood thinner for use in children aged 3 months to those younger than 12 years. At present, the only other approved blood thinner to treat venous thromboembolism (VTE) in children is dalteparin, which is administered as a subcutaneous injectionFormulations availablePellets for children aged 3 months to 12 years of ageCapsules for children aged ≥8 yearsApproved indications for dabigaran pellets Treatment of venous thromboembolism (...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now